Netherlands· NL-c8b0672d5ce2

Valganciclovir Sandoz 450 mg, filmomhulde tabletten

A valganciclovir product containing valganciclovirhydrochloride, registered in Netherlands by Sandoz B.V.. The same ATC class is registered in 18 of our 19 countries.

ATC J05AB14

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about valganciclovirhydrochlorideAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Valganciclovir is registered in 18 of 19 countries.

Countries holding a registration under ATC J05AB14 (valganciclovir), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
11 of them publish a price we can compare per daily dose

Search valganciclovir products by name

Valganciclovir · ATC J05AB14

18 / 19 countries

Belgiumprice
Canada
Czechiaprice
Denmark
Finlandprice
Franceprice
Germany
Icelandprice
Ireland
Italyprice
Netherlands
Norwayprice
Polandprice
Spainprice
Sweden
Switzerlandprice
United Kingdom
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of valganciclovir costs, country by country.

Normalised to the WHO defined daily dose (0.9 g), the median price runs from $3.83 in United States to $35.27 in Italy — a ×9.2 gap.

4 markets with a comparable price for this class
Public list prices, converted to USD at the rate date shown
US figures are pharmacy acquisition cost (CMS NADAC), not retail

Open the full comparison — free account Drug prices for market access

Valganciclovir · price per daily dose (0.9 g)

USD · FX 28 Sept 2026

IT Italy$35.27
CH Switzerland$35.18
FR France$22.39
US United States$3.83 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: VALGANCICLOVIRHYDROCHLORIDE
Manufacturer: Sandoz B.V.
Country: Netherlands (NL)
ATC code: J05AB14
ATC class: Valganciclovir
Defined daily dose: 0.9 g, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
114137

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

283 interactions on record for valganciclovir.

Graded by severity as the source publishes them — 8 severe. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check valganciclovir against other medicines How interaction checks work

Valganciclovir · interactions on record

283 records

8 severe
193 moderate
82 info

Most severe, free to view

CladribineL01BB04severe
TrospiumA03AB20moderate
Amphotericin BA07AA07moderate
TrospiumG04BD09moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Valganciclovir in 16 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All valganciclovir products

Authorised across Europe · EMA

The same active substance is authorised in 28 EEA countries. Names it is sold under:

Austria · Valcyte, Valganciclovir +pharma
Belgium · Valcyte, Valganciclovir Sandoz
Bulgaria · Алваноцит, Валцит
Cyprus · Valcyte, Valganciclovir Accord
Czechia · Cytevix, Valcyte
Germany · Valcyte, Valganaxiro
Denmark · Valcyte, Valganciclovir "medical Valley"
Estonia · Valganciclovir Accord, Valganciclovir Sandoz
Spain · Valcyte, Valganciclovir Accord
Finland · Valcyte, Valganciclovir Accord
France · Rovalcyte, Valganciclovir Accord
United Kingdom (Northern Ireland) · Valcyte, Valganciclovir Accord Healthcare
Greece · Vagotrosin, Valcyte
Croatia · Alvanocyt, Valcyte
Hungary · Valcyte, Valdamin
Ireland · Valcyte, Valganciclovir Accord Healthcare
Iceland · Valcyte, Valganciclovir Medical Valley
Italy · Valcyte, Valganciclovir Accord
Lithuania · Valganciclovir Accord, Valganciclovir Sandoz
Luxembourg · Valcyte
Latvia · Valcyte, Valganciclovir Accord
Norway · Valcyte, Valganciclovir Accord
Poland · Ceglar, Valcyte
Portugal · Rovalcyte, Valganciclovir Accord
Romania · Valganciclovir Zentiva
Sweden · Valcyte, Valganciclovir Accord
Slovenia · Ganaxa, Valcyte
Slovakia · Valdamin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/c1ef197f-f7cd-4353-a84a-ec846fda69ec
GET /v1/drugs/c1ef197f-f7cd-4353-a84a-ec846fda69ec?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Filmomhulde tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h114137_smpc_en.pdf",
  "strength": null,
  "atc_label": "Valganciclovir",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg114137",
  "excipients": [
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "CROSPOVIDON (E 1202)",
    "HYPROMELLOSE 2910 (3 - 15 mPa.s) (E 464)",
    "IJZEROXIDE ROOD  (E 172)",
    "MACROGOL 400",
    "POLYSORBAAT 80 (E 433)",
    "POVIDON K 30 (E 1201)",
    "STEARINEZUUR (E 570)",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "VALGANCICLOVIRHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h114137_piluk.pdf",
  "authorised_at": "2015/01/13",
  "procedure_number": "NL/H/3010/001",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "114137",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about valganciclovir.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console